Breast Cancer Prognostic Biomarkers: Transcriptome & Proteome Analysis

Integrating the transcriptome and proteome reveals two prognostic biomarkers for breast cancer, particularly for the estrogen receptor positive subset.

Diagnosis and prognosis of breast cancer by high-performance serum metabolic fingerprints

Druggable proteome analysis. a Correlation matrix of all 290 FDA

A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients - eBioMedicine

Integrative analysis of the proteome and transcriptome in gastric cancer identified LRP1B as a potential biomarker

Frontiers Differential Integration of Transcriptome and Proteome Identifies Pan-Cancer Prognostic Biomarkers

Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer - Computational and Structural Biotechnology Journal

Breast cancer quantitative proteome and proteogenomic landscape

Novel Genetic and Epigenetic Biomarkers of Prognostic and Predictive Significance in Stage II/III Colorectal Cancer: Molecular Therapy

Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in human breast cancers: Molecular Therapy